ACELRX PHARMACEUTICALS INC (ACRX) Stock Analyst Earnings Estimates
NASDAQ:ACRX - Nasdaq - US00444T2096 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 5.42M 136.68% | 2.82M -47.97% | 1.77M -37.23% | 520.71K -70.58% | 1.392M 167.33% | 2.554M 83.48% | 12.579M 392.52% | 28.989M 130.46% | 60.886M 110.03% | |
| EBITDA YoY % growth | -39.11M 25.56% | -34M 13.07% | -30.03M 11.68% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -40.96M 24.44% | -35.97M 12.18% | -31.68M 11.93% | -16.938M 46.53% | -17.817M -5.19% | -19.016M -6.73% | -15.343M 19.32% | 2.523M 116.44% | 30.759M 1,119.14% | |
| Operating Margin | -755.72% | -1,275.53% | -1,789.83% | -3,252.89% | -1,279.95% | -744.55% | -121.97% | 8.70% | 50.52% | |
| EPS YoY % growth | -9.60 28.36% | -5.80 39.58% | -4.34 25.17% | -1.20 72.27% | -0.80 33.90% | -0.78 2.56% | -0.58 25.66% | 0.08 114.16% | 0.93 1,037.50% |
All data in USD
| Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.19 81.13% | -0.24 67.36% | -0.27 33.70% | -0.29 -257.00% | -0.29 -51.35% |
| Revenue Q2Q % growth | 286.62K 14.65% | -100.00% | -100.00% | -100.00% | |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -3.86M 47.69% | -4.59M 13.88% | -4.794M -20.76% | -4.896M -47.92% | -4.59M -18.91% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2023 Q2Q % growth | -0.08 91.49% | -0.29 | 0.21 | 71.99% |
| Q2 2023 Q2Q % growth | -0.40 66.67% | -0.54 | 0.14 | 26.01% |
| Q1 2023 Q2Q % growth | -0.75 37.50% | -1.42 | 0.67 | 47.10% |
| Q4 2022 Q2Q % growth | -1.00 16.67% | -0.52 | -0.48 | -92.23% |
| Q3 2022 Q2Q % growth | -0.94 32.86% | -1.22 | 0.28 | 23.20% |
| Q2 2022 Q2Q % growth | -1.20 25.00% | -1.53 | 0.33 | 21.57% |
| Q1 2022 Q2Q % growth | -1.20 25.00% | -1.22 | 0.02 | 1.96% |
| Q4 2021 Q2Q % growth | -1.20 40.00% | -1.43 | 0.23 | 15.97% |
| Q3 2021 Q2Q % growth | -1.40 30.00% | -1.43 | 0.03 | 1.96% |
| Q2 2021 Q2Q % growth | -1.60 | -1.56 | -0.04 | -2.30% |
| Q1 2021 Q2Q % growth | -1.60 60.00% | -1.70 | 0.10 | 5.88% |
| Q4 2020 Q2Q % growth | -2.00 44.44% | -2.11 | 0.11 | 5.12% |
| Q3 2020 Q2Q % growth | -2.00 37.50% | -1.68 | -0.32 | -18.84% |
| Q2 2020 Q2Q % growth | -1.60 50.00% | -2.81 | 1.21 | 42.96% |
| Q1 2020 Q2Q % growth | -4.00 -17.65% | -3.47 | -0.53 | -15.34% |
| Q4 2019 Q2Q % growth | -3.60 | -4.01 | 0.41 | 10.33% |
| Q3 2019 Q2Q % growth | -3.20 | -4.54 | 1.34 | 29.55% |
| Q2 2019 Q2Q % growth | -3.20 | -4.47 | 1.27 | 28.42% |
| Q1 2019 Q2Q % growth | -3.40 | -4.54 | 1.14 | 25.07% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2023 Q2Q % growth | 120K | 134.13K | -14.13K | -10.53% |
| Q2 2023 Q2Q % growth | 250K | 76.5K | 173.5K | 226.80% |
| Q1 2023 Q2Q % growth | 612K | -612K | -100.00% | |
| Q4 2022 Q2Q % growth | 250K | 4.59M | -4.34M | -94.55% |
| Q3 2022 Q2Q % growth | -100.00% | 637.5K | -637.5K | -100.00% |
| Q2 2022 Q2Q % growth | -100.00% | 561K | -561K | -100.00% |
| Q1 2022 Q2Q % growth | -100.00% | 561K | -561K | -100.00% |
| Q4 2021 Q2Q % growth | -100.00% | 1.887M | -1.887M | -100.00% |
| Q3 2021 Q2Q % growth | 1.86M 35.77% | 1.938M | -78K | -4.02% |
| Q2 2021 Q2Q % growth | 440K -84.93% | 1.845M | -1.405M | -76.15% |
| Q1 2021 Q2Q % growth | 510K 30.77% | 1.079M | -569K | -52.73% |
| Q4 2020 Q2Q % growth | 740K 54.17% | 1.764M | -1.024M | -58.05% |
| Q3 2020 Q2Q % growth | 1.37M 124.59% | 2.891M | -1.521M | -52.61% |
| Q2 2020 Q2Q % growth | 2.92M 210.64% | 2.064M | 856K | 41.47% |
| Q1 2020 Q2Q % growth | 390K 44.44% | 1.894M | -1.504M | -79.41% |
| Q4 2019 Q2Q % growth | 480K | 1.029M | -549K | -53.35% |
| Q3 2019 Q2Q % growth | 610K | 981.536K | -371.536K | -37.85% |
| Q2 2019 Q2Q % growth | 940K | 1.122M | -182K | -16.22% |
| Q1 2019 Q2Q % growth | 270K | 769.978K | -499.978K | -64.93% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 26% | 0% | 20.81% |
| Revenue | 0% | 100% | 0% | -2.76% |